September 22, 2026 - 17:57

CHEYENNE, Wyo. - A four-year continuation of the City of Cheyenne's optional 1% sales tax is a step closer to appearing on the November ballot after the Finance Committee backed the measure during a recent meeting. The proposal now moves forward for further consideration, though the final decision will rest with voters later this year.
The optional sales tax, which has been in place for several years, funds a variety of municipal projects and services. Supporters argue that extending it ensures continued investment in infrastructure, public safety, and community amenities without raising property taxes. The tax is estimated to generate millions of dollars annually, money that city officials say is essential for maintaining current service levels and addressing long-term needs.
Opponents have raised concerns about the cumulative burden on residents, particularly amid rising costs for housing, food, and utilities. Some argue that the city should explore alternative funding sources or tighten its budget before asking taxpayers to renew the tax.
The committee's recommendation does not guarantee the measure will reach the ballot. City council members must still approve the language and formally place it before voters. If approved, the question would appear during the general election in November, giving residents the final say on whether to keep the tax for another four years.
September 22, 2026 - 00:45
Meta stock jumps as Wells Fargo raises price targetMeta shares surged more than 10 percent during trading after Wells Fargo raised its price target on the stock from $640 to $796. The significant bump in the target price reflects growing confidence...
September 21, 2026 - 00:49
LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible...
September 20, 2026 - 02:49
Why Xenon Pharmaceuticals (XENE) Is Down 32.2% After Pausing Psychiatry Trials Despite Positive NDA DataXenon Pharmaceuticals saw its stock drop 32.2 percent after the company paused new enrollment in its Phase 3 trials for major depressive disorder and bipolar depression. The decision came on the...
September 19, 2026 - 21:11
Nasdaq (NDAQ) Just Made It Harder For Crypto Criminals To HideOn September 15, Nasdaq announced that its Verafin unit has partnered with Stablecore to combine traditional banking data with digital asset activity into a single financial crime detection...